To B or not to B, that is the question: the role of bleomycin in early stage Hodgkin lymphoma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-03-12
DOI
https://doi.org/10.3324/haematol.2026.300832
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

To B or not to B, that is the question: the role of bleomycin in early stage Hodgkin lymphoma

David A. Russler-Germain, Nancy L. Bartlett
Haematologica
Lymphoma Diagnosis and Treatment
article

To B or not to B, that is the question: the role of bleomycin in early stage Hodgkin lymphoma

David A. Russler-Germain, Nancy L. Bartlett
article en

Abstract

No abstract available for this paper.
Haematologica
Washington University in St. Louis (US)
Pfizer, Seagen
Zero hunger
Openalex Percentile: Top 26%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.